InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Amneal Pharmaceuticals, Inc.

AMRX Clue Score38
Fiscal year ends December CIK 0001723128 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Nikita Shah
12 Nov 2025
Executive Vice President
Sold after exercise
131,856
$11.92
$1.57M
Andrew S Boyer
20 Aug 2025
Executive Vice President
Sold after exercise
279,244
$9.38
$2.62M
John Kiely
22 Nov 2024
Director
Sold after exercise
17,058
$8.38
$142.95K
Nikita Shah
15 Mar 2021
Executive Vice President
Sold after exercise
36,330
$6.87
$249.49K
Joseph Todisco
15 Mar 2021
Executive Vice President
Sold after exercise
36,330
$6.82
$247.87K
Peter R Terreri
6 Mar 2019
Director
Sold after exercise
23,345
$12.39
$289.24K
APHC Holdings, LLC
4 May 2018
10% owner
Sold after exercise
12,328,767
$18.25
$225.00M
APHC Holdings, LLC
4 May 2018
10% owner
Sold after exercise
34,520,549
$18.25
$630.00M
Show all 88 transactions →

What was left out

Form 4 filings counted 309
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 8
Sales at will 45
Transactions with no price 0
Shares from compensation/vesting 609,293,940
Sales filed before the plan box existed 5
History held since 8 May 2018